{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T15:31:55Z","timestamp":1773675115017,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.lpm.2013.01.073","type":"journal-article","created":{"date-parts":[[2013,7,22]],"date-time":"2013-07-22T23:30:22Z","timestamp":1374535822000},"page":"27-33","source":"Crossref","is-referenced-by-count":1,"title":["Arthrite juv\u00e9nile idiopathique"],"prefix":"10.1016","volume":"43","author":[{"given":"Abdellah","family":"El Maghraoui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9783","key":"10.1016\/j.lpm.2013.01.073_bib0005","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/S0140-6736(11)60244-4","article-title":"Juvenile idiopathic arthritis","volume":"377","author":"Prakken","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2013.01.073_bib0010","doi-asserted-by":"crossref","first-page":"c6434","DOI":"10.1136\/bmj.c6434","article-title":"Diagnosis and management of juvenile idiopathic arthritis","volume":"341","author":"Prince","year":"2010","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.lpm.2013.01.073_bib0015","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1136\/ard.2010.133033","article-title":"Juvenile idiopathic arthritis: state of the art and future perspectives","volume":"69","author":"Martini","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"9563","key":"10.1016\/j.lpm.2013.01.073_bib0020","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(07)60363-8","article-title":"Juvenile idiopathic arthritis","volume":"369","author":"Ravelli","year":"2007","journal-title":"Lancet"},{"issue":"4\u00a0Suppl.\u00a055","key":"10.1016\/j.lpm.2013.01.073_bib0025","first-page":"S131","article-title":"Juvenile idiopathic arthritis. Subgroup characteristics and comparisons between rheumatoid arthritis-like subgroups and ankylosing spondylitis-like subgroups","volume":"27","author":"Horneff","year":"2009","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"10.1016\/j.lpm.2013.01.073_bib0030","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.arcped.2010.04.002","article-title":"[Guidelines for diagnosis and treatment of oligoarticular and polyarticular juvenile idiopathic arthritis]","volume":"17","author":"Bader-Meunier","year":"2010","journal-title":"Arch Pediatr"},{"issue":"9","key":"10.1016\/j.lpm.2013.01.073_bib0035","first-page":"630","article-title":"Juvenile idiopathic arthritis","volume":"39","author":"Boros","year":"2010","journal-title":"Aust Fam Physician"},{"key":"10.1016\/j.lpm.2013.01.073_bib0040","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3389\/fphar.2011.00060","article-title":"Current medical treatments for juvenile idiopathic arthritis","volume":"2","author":"Ruperto","year":"2011","journal-title":"Front Pharmacol"},{"issue":"21","key":"10.1016\/j.lpm.2013.01.073_bib0045","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1001\/jama.2011.1671","article-title":"Factors associated with treatment response to etanercept in juvenile idiopathic arthritis","volume":"306","author":"Otten","year":"2011","journal-title":"JAMA"},{"issue":"9617","key":"10.1016\/j.lpm.2013.01.073_bib0050","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(08)60454-7","article-title":"Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial","volume":"371","author":"Yokota","year":"2008","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.lpm.2013.01.073_bib0055","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/art.20946","article-title":"Targeting the interleukin-6\u00a0receptor: a new treatment for systemic juvenile idiopathic arthritis?","volume":"52","author":"de Benedetti","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"9617","key":"10.1016\/j.lpm.2013.01.073_bib0060","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0140-6736(08)60428-6","article-title":"Tocilizumab for rheumatoid and juvenile idiopathic arthritis","volume":"371","author":"Bongartz","year":"2008","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.lpm.2013.01.073_bib0065","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.autrev.2012.07.022","article-title":"Systemic juvenile idiopathic arthritis","volume":"12","author":"Martini","year":"2012","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.lpm.2013.01.073_bib0070","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/acr.20337","article-title":"Cost-effectiveness of biologics in polyarticular-course juvenile idiopathic arthritis patients unresponsive to disease-modifying antirheumatic drugs","volume":"63","author":"Ungar","year":"2011","journal-title":"Arthritis Care Res"},{"issue":"4","key":"10.1016\/j.lpm.2013.01.073_bib0075","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/acr.20460","article-title":"2011\u00a0American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features","volume":"63","author":"Beukelman","year":"2011","journal-title":"Arthritis Care Res"},{"issue":"3","key":"10.1016\/j.lpm.2013.01.073_bib0080","first-page":"264","article-title":"Juvenile idiopathic arthritis \u2013 An update on pharmacotherapy","volume":"69","author":"Kahn","year":"2011","journal-title":"Bull NYU Hosp Jt Dis"},{"issue":"10","key":"10.1016\/j.lpm.2013.01.073_bib0085","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nrrheum.2010.142","article-title":"The safety profile of biologic therapies for juvenile idiopathic arthritis","volume":"6","author":"Hashkes","year":"2010","journal-title":"Nat Rev Rheumatol"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498213006556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498213006556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T11:52:24Z","timestamp":1539517944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498213006556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0755498213006556"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2013.01.073","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}